AbbVie Biotech Ventures is AbbVie's corporate strategic venture capital arm, established to invest in novel, transformational therapeutics at discovery and preclinical stages. The firm focuses on a variety of therapeutic areas including oncology, immunology, neuroscience, and aesthetics, with a commitment to improving human health.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions